Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. - Wikidata - awgldk - TriplyDB

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

http://www.wikidata.org/entity/Q37099954

about

Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.Effects of essential fatty acid deficiency on prostaglandin E2 production and cell-mediated immunity in a mouse model of leprosy.Definition of a human suppressor T-cell epitope.An analysis of in vitro T cell responsiveness in lepromatous leprosy.Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta.Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals.

P2860

Q34297445-F0E8626B-0883-4C93-9505-1C9AC5D46582 Q35544857-336023C8-8398-4BEB-9854-90453EA2EF27 Q35788916-0DF84F6B-DACE-4736-9F1A-F51C823072C8 Q36350785-2667CD72-26E4-4BE6-8128-C131A854D863 Q36352322-B9E59A33-6B76-489A-89BE-B29455A5C87A Q36355451-6A56B1DE-741F-4F08-B47D-D5D8F412625F Q37024961-C4C0A7CB-EE15-4913-AABE-ECD3FC24B0FB Q37488015-0D2FC024-68C3-408D-AD0C-F5E35D6AB4B1 Q40166540-AB5CC150-03AB-4777-B382-377B9318BE2B Q40426840-2A97E118-6983-42A5-8B00-E34186C1A7E0

P2860

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

http://www.wikidata.org/entity/Q37099954

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 1983

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Monocyte-derived soluble suppressor factor

@nl

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

@en

type

label

Monocyte-derived soluble suppressor factor

@nl

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

@en

prefLabel

Monocyte-derived soluble suppressor factor

@nl

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

@en

P1433

Q37099954-38660A2A-6306-4727-A0D8-A85C83B3B004

P1476

Q37099954-57DF9BD9-5322-405D-AD37-007B0F8A147A

P2093

Q37099954-6F448BA6-63E0-4478-A72D-D430B7325F5B

Q37099954-92C9295C-38FA-44EF-B8EC-81773735B257

Q37099954-9B219511-37D5-466A-AD7F-752E2A340406

Q37099954-CD853E97-1257-49FC-A241-7E80572BBBD6

P2860

Q37099954-1899140B-801F-417B-A51C-0C92D85BC6C7

Q37099954-1BCBFCDE-92CB-43C9-A5FD-FA15F71AC900

Q37099954-392050BF-B2D6-4CB3-93A5-E084EEA5B53A

Q37099954-3D41A38C-BC9C-4B29-94A5-50B614633757

Q37099954-44A410F9-AA3D-4D72-AFBF-991CE0514910

Q37099954-588DBF57-E001-42D2-8E84-5E30EC5B22B8

Q37099954-602F4BB0-C1D3-4D85-AA15-C85B3FB24FB1

Q37099954-64CECAED-4C4E-4C11-A56F-D8B7B74489B3

Q37099954-6D4C921A-536B-4EB4-BC6E-CDBAFD9B201D

Q37099954-7A59EF8F-7256-4F13-81DD-239333148EE7

P304

Q37099954-6F0C9E47-4CB8-4381-9DE2-18DB6844C4EF

P31

Q37099954-71182263-803B-4276-9BD3-887ED52B8AC1

P407

Q37099954-12F8451D-A6ED-4EB0-877B-9FB3F6D32C90

P433

Q37099954-58374657-87F7-4449-B2F1-A8AC0C6BB035

P478

Q37099954-7D18DFA5-8051-4D56-92A0-82F7645ED3D1

P577

Q37099954-FE6D7C8F-2F37-4826-A67B-3AF8FA6488F6

P698

Q37099954-A5BBF1FF-8970-4C1A-B215-6FE8D2F4FCD6

P921

Q37099954-93181454-077C-4C9F-8E68-A95C1F5B5DCC

P932

Q37099954-343115B1-B7E6-47F1-9DBB-2C1016DBEC41

P1433

Infection and Immunity

P1476

Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy

@en

P2093

Bhutani LK

http://www.w3.org/2001/XMLSchema#string

Nath I

http://www.w3.org/2001/XMLSchema#string

Sathish M

http://www.w3.org/2001/XMLSchema#string

Sharma AK

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of leprosy according to immunity. A five-group system.

Suppression of in vitro cytotoxic response by macrophages due to induced arginase

Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis.

Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis

Modulation of the host response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocyte proliferative responses to parasite antigens.

The macrophage as a secretory cell.

Concanavalin A induced suppressor activity in human leprosy.

Immunological phenomena in leprosy and related diseases.

Regulation of the immune response by prostaglandins.

Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

P304

890-899

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1983-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6605932

http://www.w3.org/2001/XMLSchema#string

P921

P932

264383

http://www.w3.org/2001/XMLSchema#string